Materials and Methods for Isolating Self-Antigen Polypeptides

USPTO granted Patent US12590120B2 to Impact Proteomics for methods of isolating self-antigen polypeptides. The patent application (No. 18438790) was filed February 12, 2024, and the grant includes 19 claims covering the materials and methods disclosed. CPC classifications indicate applications in protein/peptide isolation and enzyme-related biochemistry.

Organizations in biotechnology, pharmaceutical research, or diagnostic development should review this grant to assess potential freedom-to-operate implications. While patents grant exclusive rights rather than impose compliance obligations, companies developing competing technologies in self-antigen isolation or related protein chemistry may need to consider licensing or design-around strategies. Patent grants do not carry compliance deadlines or penalties.